Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Let our experienced team handle your delivery
Sitohang, Dr I
In a statement, Eli Lilly, the manufacturer of Retatrutide, told RT Investigates the product has not been reviewed or approved by the US Food and Drug Administration, the European Medicines Agency, or any regulatory agency anywhere in the world and therefore at this time no one can sell it for human use
Outcomes depend on factors like lifestyle, metabolism, and adherence to the treatment plan
Worsening diabetic retinopathy: Rapid improvement in blood sugar can temporarily worsen eye damage in diabetic patients
Type 2 Diabetes Models: Phase 3 TRANSCEND-T2D-1 data demonstrated HbA1c reductions of 1.7-2.0% and mean weight loss of 36.6 lbs over 40 weeks
US$ 24.09
US$ 25.08
US$ 24.93
US$ 26.23
US$ 28.60
US$ 25.33
US$ 28.49
